Leo Pharma closes massive dermatology deal
Denmark’s Leo Pharma has now finalised its EUR 675 million takeover of Japan-based group Astellas’ dermatology division.
BY STEFAN SINGH KAILAY
The global dermatology business of Japanese drug group Astellas Pharma has now finally been transferred to Leo Pharma, the companies said in a press release Friday. The deal was first announced in November last year and the transaction process has now been finalised.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Leo Pharma in EUR 675 million acquisition
For abonnenter
